APLS logo

Apellis Pharmaceuticals, Inc. (APLS) Revenue

Annual Revenue:

$781.37M+$384.78M(+97.02%)
December 31, 2024

Summary

  • As of today, APLS annual revenue is $781.37 million, with the most recent change of +$384.78 million (+97.02%) on December 31, 2024.
  • During the last 3 years, APLS annual revenue has risen by +$714.80 million (+1073.88%).
  • APLS annual revenue is now at all-time high.

Performance

APLS Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

Quarterly Revenue:

$458.58M+$280.08M(+156.92%)
September 30, 2025

Summary

  • As of today, APLS quarterly revenue is $458.58 million, with the most recent change of +$280.08 million (+156.92%) on September 30, 2025.
  • Over the past year, APLS quarterly revenue has increased by +$261.75 million (+132.98%).
  • APLS quarterly revenue is now at all-time high.

Performance

APLS Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

TTM Revenue:

$1.02B+$261.75M(+34.68%)
September 30, 2025

Summary

  • As of today, APLS TTM revenue is $1.02 billion, with the most recent change of +$261.75 million (+34.68%) on September 30, 2025.
  • Over the past year, APLS TTM revenue has increased by +$301.18 million (+42.11%).
  • APLS TTM revenue is now at all-time high.

Performance

APLS TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

APLS Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+97.0%+133.0%+42.1%
3Y3 Years+1073.9%+1979.2%+799.1%
5Y5 Years+100.0%+10000.0%+10000.0%

APLS Revenue Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+1073.9%at high+1979.2%at high+1247.6%
5Y5-Yearat high>+9999.0%at high>+9999.0%at high>+9999.0%
All-TimeAll-Timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

APLS Revenue History

DateAnnualQuarterlyTTM
Sep 2025
-
$458.58M(+156.9%)
$1.02B(+34.7%)
Jun 2025
-
$178.49M(+7.0%)
$754.65M(-2.7%)
Mar 2025
-
$166.80M(-21.5%)
$775.84M(-0.7%)
Dec 2024
$781.37M(+97.0%)
$212.53M(+8.0%)
$781.37M(+9.2%)
Sep 2024
-
$196.83M(-1.4%)
$715.22M(+13.7%)
Jun 2024
-
$199.69M(+15.9%)
$628.79M(+20.0%)
Mar 2024
-
$172.32M(+17.7%)
$524.07M(+32.1%)
Dec 2023
$396.59M(+425.8%)
$146.38M(+32.6%)
$396.59M(+45.3%)
Sep 2023
-
$110.40M(+16.2%)
$272.88M(+47.9%)
Jun 2023
-
$94.97M(+111.8%)
$184.53M(+74.3%)
Mar 2023
-
$44.85M(+97.9%)
$105.89M(+40.4%)
Dec 2022
$75.42M(+13.3%)
$22.66M(+2.8%)
$75.42M(-33.3%)
Sep 2022
-
$22.06M(+35.1%)
$113.05M(+17.0%)
Jun 2022
-
$16.32M(+13.5%)
$96.64M(+19.4%)
Mar 2022
-
$14.38M(-76.1%)
$80.94M(+21.6%)
Dec 2021
$66.56M
$60.29M(+967.1%)
$66.56M(-74.0%)
Sep 2021
-
$5.65M(+806.9%)
$256.27M(+2.0%)
Jun 2021
-
$623.00K(>+9900.0%)
$251.27M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2021
-
$0.00(-100.0%)
$250.65M(0.0%)
Dec 2020
$250.65M(>+9900.0%)
$250.00M(>+9900.0%)
$250.65M(>+9900.0%)
Sep 2020
-
$646.00K(>+9900.0%)
$646.00K(>+9900.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2019
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2017
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2017
-
$0.00
$0.00
Dec 2016
$0.00(0.0%)
-
-
Dec 2015
$0.00(0.0%)
-
-
Dec 2014
$0.00(0.0%)
-
-
Dec 2013
$0.00
-
-

FAQ

  • What is Apellis Pharmaceuticals, Inc. annual revenue?
  • What is the all-time high annual revenue for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. annual revenue year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. quarterly revenue?
  • What is the all-time high quarterly revenue for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. quarterly revenue year-on-year change?
  • What is Apellis Pharmaceuticals, Inc. TTM revenue?
  • What is the all-time high TTM revenue for Apellis Pharmaceuticals, Inc.?
  • What is Apellis Pharmaceuticals, Inc. TTM revenue year-on-year change?

What is Apellis Pharmaceuticals, Inc. annual revenue?

The current annual revenue of APLS is $781.37M

What is the all-time high annual revenue for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high annual revenue is $781.37M

What is Apellis Pharmaceuticals, Inc. annual revenue year-on-year change?

Over the past year, APLS annual revenue has changed by +$384.78M (+97.02%)

What is Apellis Pharmaceuticals, Inc. quarterly revenue?

The current quarterly revenue of APLS is $458.58M

What is the all-time high quarterly revenue for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high quarterly revenue is $458.58M

What is Apellis Pharmaceuticals, Inc. quarterly revenue year-on-year change?

Over the past year, APLS quarterly revenue has changed by +$261.75M (+132.98%)

What is Apellis Pharmaceuticals, Inc. TTM revenue?

The current TTM revenue of APLS is $1.02B

What is the all-time high TTM revenue for Apellis Pharmaceuticals, Inc.?

Apellis Pharmaceuticals, Inc. all-time high TTM revenue is $1.02B

What is Apellis Pharmaceuticals, Inc. TTM revenue year-on-year change?

Over the past year, APLS TTM revenue has changed by +$301.18M (+42.11%)
On this page